OTC Markets EXMKT - Delayed Quote USD

Rejuvel Bio-Sciences, Inc. (NUUU)

Compare
0.0000 0.0000 (0.00%)
At close: October 18 at 4:00 PM EDT
Loading Chart for NUUU
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0001
  • Volume 500,000
  • Avg. Volume 0
  • Market Cap (intraday) 5,184
  • Beta (5Y Monthly) -133.10
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand. It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities. The company was formerly known as Technology Applications International Corporation and changed its name to Rejuvel Bio-Sciences, Inc. in June 2015. Rejuvel Bio-Sciences, Inc. was founded in 2009 and is headquartered in Miami, Florida.

www.rejuvel.com

1

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NUUU

View More

Performance Overview: NUUU

Trailing total returns as of 10/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NUUU
0.00%
S&P 500
22.95%

1-Year Return

NUUU
90.00%
S&P 500
34.10%

3-Year Return

NUUU
90.00%
S&P 500
31.16%

5-Year Return

NUUU
95.00%
S&P 500
95.62%

Compare To: NUUU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NUUU

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -329.05%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    187.33k

  • Net Income Avi to Common (ttm)

    -1.05M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    877

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    228.03k

Research Analysis: NUUU

View More

Company Insights: NUUU

Research Reports: NUUU

View More

People Also Watch